Status: No longer developing NGS platform Back in 2008 Affymetrix stated that they would start developing a chip combining DNA capture and enzymatic-based sequencing. While it is unclear how far along this technology was developed, Affymetrix has never released such a product and has since stated that they are not going to directly enter the […]
Sequencing companies are born and sequencing companies die. Or get acquired. Or just change their names. We honor those that have come before us.
Status: technology sold off Agencourt Bioscience was developing a ‘sequencing-by-ligation’ system when they were acquired by Beckman in 2005. Beckman retained the sequencing services business, while Agencourt Personal Genomics was spun out to continue developing the NGS platform technology. APG was then acquired by ABI (now called Life Technologies) in 2006 for $120M. APG’s technology […]
Status: acquired Avantome was co-founded in 2008 by Mostafa Ronaghi, a co-inventor of the pyrosequencing technology. They were working on the development of a low cost, long read system based on pyrosequencing technology when they were acquired by Illumina in 2008 for $60M. Illumina purchased the technology to complement their sequencing portfolio and to form […]
Status: name change BioNanomatrix changed their name to BioNano Genomics in 2011. Please contact us at firstname.lastname@example.org if you have any information or opinions you’d like to share about this page.
Status: ceased operations Genizon Biosciences was developing sequencing technology based on ‘sequencing-by-hybridization’ of rolling circle amplicons. The technology was never launched and the company ceased operations in 2011. Please contact us at email@example.com if you have any information or opinions you’d like to share about this page.
Halcyon Molecular was developing a system based on electron microscopy. The system was intended to work by stretching out very long individual molecules of DNA (up to 150kb) and staining them with contrast agents, allowing for the determination of individual bases with an electron microscope. When founded in 2009, the company claimed to be aiming […]
General Overview Intelligent Bio-Systems had been developing their sequencing-by-synthesis (SBS) chemistry, which it licensed exclusively from Jengyue Ju and Columbia University, since 2006. In 2011 they released their first next-gen sequencer, the MAX-Seq, through a collaboration with Danaher Motion’s Dover and Azco Biotech. With the acquisition of IBS by Qiagen in 2012, the company may […]
Status: merged and acquired Lynx developed their MPSS (“massively parallel signature sequencing”) technology for generating tag-based RNA sequencing data. They were acquired by Solexa in 2005 via a reverse merger (Lynx was a public company and took the Solexa name and management). The combined company was acquired by Illumina in 2006. Please contact us at […]
Status: ceased operations; technology acquired Manteia developed the initial ‘bridge amplification’ technology that is currently used by Illumina sequencers. They were shut down in 2003 by their owners, Serono, and the technology was sold to Solexa (and Lynx) in 2004 to help them make their move away from single molecule sequencing. Please contact us at […]
Status: name change Nanofluidics changed their name to Pacific Biosciences in 2005. Please contact us at firstname.lastname@example.org if you have any information or opinions you’d like to share about this page.